Children's Hospital Academic Medical Organization (CHAMO) MyChart Study (NCT05979077)
Improving Quality of Care in Diabetes Clinic Through Patient-Entered Electronic Health Data?
๐ฉบ Plain-English Summary (8th-Grade Level)
Evolving technology and clinical innovation have led to dramatic changes in the management of type 1 diabetes (T1D). These changes have led to a need to collect a growing number of details from families during their visits. As a result, much of the physician-patient visit is spent transferring information instead of focusing on diabetes care, contributing to increased time pressures in clinic and unmet needs for patients. In response to this reality, the investigators have developed a tool that allows families to input their diabetes-related information into their physicians' electronic health record (EHR) documentation tool before their clinic visit, using a questionnaire administered via CHEO's secure patient portal (MyChartยฎ). The investigators will evaluate the impact of an integrated electronic patient questionnaire, on quality of care (patient-reported), diabetes control and clinic efficiency. The investigators hope that our study will determine whether having families input clinical data prior to a visit is an effective strategy to improve the quality of diabetes care. The investigators believe that the findings will be of interest to all those studying the value of incorporating patient-entered data both within diabetes care and beyond.
Who can join: Review the eligibility criteria below.
Location: Children's Hospital of Eastern Ontario - Research Institute โ Ottawa, Ontario
Age range: 0 Years to 131 Months
๐งช Interventions in This Study
- MyChart Questionnaire (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Children's Hospital of Eastern Ontario - Research Institute โ Ottawa, Ontario
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus, Type 1
- Testing an Integrated Care Model Trial โ Atlanta, Georgia
- Safety of ENC-201-CED ENCRT โ Toronto, Ontario
- Teplizumab in Pediatric Stage 2 Type 1 Diabetes โ San Francisco, California
- Allogenic Islet Cell Transplantation โ Chicago, Illinois
- Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells โ Charleston, South Carolina
- Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes โ Stanford, California
Explore by condition: All Diabetes Mellitus, Type 1 clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.